SystImmune is eligible to receive up to an additional $250 million in contingent near-term payments and additional payments ...

Cold Chain Technologies has completed a project demonstrating the viability of ocean freight for transporting ...

Quotient Sciences and Biorasi have partnered to deliver fully integrated early phase clinical trial solutions.

BioMed X has launched XFem Labs, a new Women’s Health R&D Accelerator in Heidelberg. The initiative, which is supported by the Gates Foundation, intends to establish a world-class women’s health ...

Apprentice.io, the creator of an AI-powered manufacturing platform for life sciences, has partnered with Aprecia, a leader in ...

AstraZeneca has also reached an agreement with the U.S. Department of Commerce to delay Section 232 tariffs for three years, ...

Bend Bioscience, a U.S.-based CDMO specializing in small-molecule drug development and manufacturing, has expanded its footprint in Oregon with four new GMP manufacturing and process development ...

Supports pharmaceutical companies from early development through commercial manufacturing and packaging.

Bristol Myers Squibb has agreed to acquire Orbital Therapeutics, a privately held biotechnology company pioneering a new ...

Global Supply Chain Centers connect innovation with infrastructure, providing an integrated platform that safeguards advanced ...

Aims to design a vaccine capable of inducing an immune response with bactericidal activity against Pseudomonas aeruginosa.

Aims to address formulation, drug persistence, and delivery challenges by enabling sustained release and enhanced solubility.